chr16-88643304-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000101.4(CYBA):c.*49T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.624 in 1,358,570 control chromosomes in the GnomAD database, including 268,002 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.69 ( 36858 hom., cov: 31)
Exomes 𝑓: 0.62 ( 231144 hom. )
Consequence
CYBA
NM_000101.4 3_prime_UTR
NM_000101.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.744
Genes affected
CYBA (HGNC:2577): (cytochrome b-245 alpha chain) Cytochrome b is comprised of a light chain (alpha) and a heavy chain (beta). This gene encodes the light, alpha subunit which has been proposed as a primary component of the microbicidal oxidase system of phagocytes. Mutations in this gene are associated with autosomal recessive chronic granulomatous disease (CGD), that is characterized by the failure of activated phagocytes to generate superoxide, which is important for the microbicidal activity of these cells. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-88643304-A-G is Benign according to our data. Variant chr16-88643304-A-G is described in ClinVar as [Benign]. Clinvar id is 1172927.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.829 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYBA | NM_000101.4 | c.*49T>C | 3_prime_UTR_variant | 6/6 | ENST00000261623.8 | NP_000092.2 | ||
CYBA | XM_011522905.4 | c.*1862T>C | 3_prime_UTR_variant | 6/6 | XP_011521207.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYBA | ENST00000261623.8 | c.*49T>C | 3_prime_UTR_variant | 6/6 | 1 | NM_000101.4 | ENSP00000261623 | P1 |
Frequencies
GnomAD3 genomes AF: 0.690 AC: 104570AN: 151652Hom.: 36808 Cov.: 31
GnomAD3 genomes
AF:
AC:
104570
AN:
151652
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.618 AC: 44774AN: 72504Hom.: 14052 AF XY: 0.620 AC XY: 25486AN XY: 41116
GnomAD3 exomes
AF:
AC:
44774
AN:
72504
Hom.:
AF XY:
AC XY:
25486
AN XY:
41116
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.616 AC: 742928AN: 1206800Hom.: 231144 Cov.: 18 AF XY: 0.617 AC XY: 366682AN XY: 594336
GnomAD4 exome
AF:
AC:
742928
AN:
1206800
Hom.:
Cov.:
18
AF XY:
AC XY:
366682
AN XY:
594336
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.690 AC: 104673AN: 151770Hom.: 36858 Cov.: 31 AF XY: 0.694 AC XY: 51469AN XY: 74170
GnomAD4 genome
AF:
AC:
104673
AN:
151770
Hom.:
Cov.:
31
AF XY:
AC XY:
51469
AN XY:
74170
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2604
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 85% of patients studied by a panel of primary immunodeficiencies. Number of patients: 81. Only high quality variants are reported. - |
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jun 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at